AZD0530 and Gemcitabine in Locally Advanced/Metastatic Pancreatic Cancer That Cannot Be Removed By Surgery
Phase 1/2 Completed
34 enrolled
Irinotecan and Docetaxel With or Without Cetuximab in Treating Patients With Metastatic Pancreatic Cancer
Phase 2 Completed
94 enrolled 10 charts
Gemcitabine With or Without Radiation Therapy in Treating Patients With Pancreatic Cancer
Phase 3 Completed
74 enrolled 9 charts
Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Pancreas
Phase 2 Completed
Chemotherapy and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer
Phase 2 Completed
Ondansetron With/Out Dexamethasone to Prevent Vomiting in Patients Receiving Radiation to the Upper Abdomen
Phase 3 Completed
211 enrolled
Gemcitabine With/Out Erlotinib in Unresectable Locally Advanced/Metastatic Pancreatic Cancer
Phase 3 Completed
569 enrolled
Study of Blood Samples From Patients With Malignant Melanoma, Metastatic Breast Cancer, Advanced Lung Cancer, Pancreatic Cancer, or Colorectal Cancer.
Completed
803 enrolled
S9924 R115777 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
Phase 2 Completed
58 enrolled
S0205 Gemcitabine w/ or w/o Cetuximab as First-Line Therapy in Locally Advanced Pancreas Cancer
Phase 3 Completed
766 enrolled
Ganitumab and Gemcitabine Hydrochloride Followed by Radiation Therapy, Ganitumab, Capecitabine, and Maintenance Therapy in Treating Patients With Locally Advanced Cancer of the Pancreas
Phase 1 Completed
8 enrolled
Lapatinib Ditosylate and Capecitabine in Treating Patients With Metastatic Pancreatic Cancer
Phase 2 Completed
9 enrolled
Fluorouracil, Gemcitabine, and Radiation Therapy in Treating Patients With Cancer of the Pancreas
Phase 3 Completed
518 enrolled
Radiation Therapy Plus Paclitaxel in Treating Patients With Nonmetastatic, Unresectable Pancreatic Cancer
Phase 2 Completed
122 enrolled
Incidence of Blood Clots in Patients Undergoing Chemotherapy for Solid Tumors
Completed
64 enrolled
S9700 Combination Chemotherapy in Treating Patients With Stage II or Stage III Pancreatic Cancer
Phase 2 Completed
54 enrolled
Docetaxel and Gemcitabine Compared With Docetaxel and Cisplatin in Treating Patients With Metastatic or Locally Advanced Pancreatic Cancer
Phase 2 Completed
96 enrolled
Glufosfamide With or Without Hydration in Treating Patients With Advanced Pancreatic Cancer
Phase 2 Completed
35 enrolled
Gemcitabine and Radiation Therapy Compared With Gemcitabine Alone in Treating Patients Who Have Undergone Surgery for Pancreatic Cancer
Phase 2/3 Completed
97 enrolled
Fluorouracil With or Without Cisplatin in Treating Patients With Advanced or Metastatic Cancer of the Pancreas
Phase 3 Completed
200 enrolled